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VERBURG-VAN KEMENADE, B. M. L., B. G. JENKS, P. M. J. M. CRUIJSEN, A. DINGS, M.-C. TONON AND H. 
VAUDRY. Regulation of MSH release from the neurointermediate lobe of Xenopus laevis by CRF-like peptides. PEP- 
TIDES 8(6) 1093-1100, 1987.--Immunocytochemical studies howed the presence of a fiber system containing aCRF-like 
peptide in the median eminence and in the neural obe of the pituitary gland ofXenopus laevis. During in vitro superfusion 
of neurointermediate lobe tissue, CRF, sauvagine and urotensin I induced a rapid and dose-dependent stimulation of 
secretion of MSH and endorphin. Tissue of white-background a apted animals displayed aremarkably higher sensitivity to 
CRF and sauvagine than tissue from animals that were adapted to a black background. During superfusion of isolated 
melanotrope cells in suspension, itwas shown that CRF and sauvagine exerted their effect directly on the melanotrope c ll. 
We therefore conclude that there is morphological nd biochemical evidence to consider a CRF-like peptide as a physiolog- 
ical MSH-releasing factor. 
Neurointermediate lobe MSH release CRF Sauvagine Urotensin 
CORTICOTROPIN-releasing factor (CRF) is a 41 amino acid 
peptide [31] which is well-established aspotent stimulator of 
in vivo [27-29] and in vitro [28,36] ACTH secretion 
from the mammalian anterior pituitary gland. It has been 
shown that in two non-mammalian vertebrate species, the 
goldfish 110,11] and the frog Rana ridibunda [34], CRF is 
also able to stimulate ACTH secretion from corticotrope 
cells. The proposed neuroendocrine function for this peptide 
in mammals is supported by its immunocytochemical 
demonstration i the hypothalamus, median eminence and 
neural lobe [44]. A similar distribution of immunoreactive 
material has been shown for lower vertebrate species, in- 
cluding the goldfish and the frog Rana ridibunda [33,44]. In 
this latter species some fibers were also found in the pars 
intermedia, indicating that a CRF-like peptide could also be 
involved in the neuroendocrine r gulation of the release of 
MSH from the intermediate lobe of the pituitary, In this 
regard, it has been shown for the rat that ovine CRF (o-CRF) 
is able to stimulate release of a-MSH [2, 26, 301. Bovine 
intermediate lobe cells could, however, not be stimulated 
[4]. Despite the positive CRF immunoreaction i  the pars 
intermedia of Rana, the peptide had no effect on the in vitro 
release of c~-MSH from the neurointermediate lobe of this 
species [34]. 
The non-mammalian peptides, sauvagine and urotensin I, 
show a remarkable sequence homology with CRF [8, 17, 18, 
25]. As many as 20 of the 40 amino acids are found in a 
homologous region, while 12 other amino acids could be ac- 
counted for by a single base-pair change of their genetic 
code. Urotensin I has been isolated from teleost fish 
Urophysis and sauvagine from the skin of the South Ameri- 
can frog Phylomedusa uvagea. Sauvagine and urotensin I 
are potent ACTH releasing factors in the rat [6, 8, 16, 28]. 
Also, in fish they may stimulate ACTH secretion [9, 10, 11, 
17]. Corticotrope and intermediate lobe cells of Rana 
ridibunda, however, were insensitive to these peptides [34]. 
In view of the species-specific findings reported above for 
CRF, we have investigated the involvement of CRF-related 
peptides in the regulation of secretion from the intermediate 
lobe melanotropes ofXenopus laevis. The pars intermedia of 
this amphibian plays an important role in the process of 
background adaptation, namely the secretion of MSH when 
the animal is on a black background [3, 5, 14]. It has already 
been shown that MSH release is controlled by classical 
neurotransmitters [21, 39, 41, 43] and by peptidergic fac- 
tors [38,42] of hypothalamic origin. 
In our investigation of possible involvement of CRF- 
related peptides in the regulation of the pars intermedia of 
Xenopus laevis, we have (1) determined by im- 
munocytochemistry if there is a morphological basis for 
regulation through CRF-like peptides, (2) examined the ef- 
fects of CRF, sauvagine and urotensin I on release of MSH 
during in vitro superfusion of neurointermediate lobe tissue, 
and (3) examined the response of isolated melanotropes to
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FIG. 1. CRF immunocytochemistry of the pituitary gland ofXenopus laevis, (a) anti-o-CRF staining in pituitary gland and median eminence of 
a white-background a apted animal shown at 105x magnification, and (b) shown at 140x magnification; (c) the anti-CRF staining in the 
pituitary gland and median eminence of a black-background adapted animal (105 x ); (d) adjacent section after immunoabsorption with o-CRF. 
these peptides to determine if they function through direct 
action on the MSH-celI. a-MSH is derived from a large pre- 
cursor protein, pro-opiomelanocortin (POMC), which in 
Xenopus melanotrope cells is proteolyticaUy cleaved to form 
a number of peptides including endorphin [20,22]. We there- 
fore extended our analysis to include the effect of CRF- 
related peptides in the secretion of immunoreactive 
endorphin in order to examine the possible occurrence of 




Xenopus laevis were bred in our aquatic facility and 
reared on a grey background. Prior to the experiments, the 
animals were adapted for at least two weeks to white or 
black backgrounds at 22°C and constant illumination. 
Immunocytochemistry With Anti-CRF 
Brain and pituitary tissue were fixed in Bouin-Hollande, 
paraplast embedded, and 5/zm sections were immunostained 
overnight at 4°C with the peroxidase-anti-peroxidase method 
according to Sternberger [32] using 4 Cl-naphtol as oxygen 
acceptor. The C-terminally directed antiserum (code CI 24), 
dilution 1:150, was raised against o-CRF and was provided 
by Dr. L. Linton (Redding, England). In radioimmunoassays 
the antibody did not show cross-reactivity with sauvagine or 
urotensin [19]. Control experiments were performed after 
adsorption of the antiserum with o-CRF or sauvagine. 
In vitro Superfusion of Neurointermediate Lobe Tissue 
Our superfusion system contains four independent super- 
fusion chambers (10/zl volume each). A single neurointer- 
mediate lobe was placed in each chamber and incubation 
medium (112 mM NaC1, 2 mM KC1, 2 mM CaClz, 15 mM 
Hepes pH 7.38, 0.3 mg/ml BSA, 2 mg/ml glucose and carbo- 
gen aerated) was pumped through the chambers at a rate of 
1.5 ml/hr at 22°C. Fractions of 7.5 min were collected and 
stored at -20°C until submission to radioimmunoassay for
MSH or endorphin. After a 1 hr equilibration period a super- 
fusion medium was given which contained o-CRF, sauvagine 
or urotensin. After a 15 min pulse the system was switched 
again to standard incubation medium. Maximum superfusion 
time was 6 hr during which a maximum of four pulses of 
neuropeptide could be given. Results of separate xperi- 
ments are expressed as a percentage ofbasal secretion; 100% 
basal secretion is defined as the average MSH or endorphin 
value that was measured during the 15 rain before se- 
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FIG. 2. Effect of CRF (10 -8, 10 -7, 10 6 M) or sauvagine (10 -~, 10 -r, 10 -6 M) on MSH secretion during in 
vitro superfusion of neurointermediate lobes of white- (top profiles) and of black-background (bottom 
profiles) adapted animals. Neuropeptides were administered during 15 min periods as indicated in the 
figure. Each figure represents he average of several individual lobes (n=number of lobes). The 100% 
values of basal secretion were defined from the average MSH secretion during 15 min before the 
administration f secretagogues. These values were for lobes of white-background a apted animals, 
CRF 10 -8 M: 1012 pg/7.5 rain, 10 -r M" 1878 pg/7.5 min, 10 -6 M: 1629 pg/7.5 min, sauvagine 10 -5 M: 960 
pg/7.5 min, 10 -7 M: 1116 pg/7.5 min, 10 -~ M: 1317 pg/7.5 min; for lobes of black-background adapted 
animals, CRF 10 -8 M: 1588 pg/7.5 min, 10 -7 M: 1871 pg/7.5 min, 10 -6 M: 5538 pg/7.5 min, sauvagine 
10 -5 M: 1340 pg/7.5 rain, 10 -1 M: 1931 pg/7.5 min, 10 `6 M: 1351 pg/7.5 min. 
cretagogue addition. Results of the individual lobes were then 
averaged and SEM values were calculated. 
Preparation of Cell Suspensions 
Preparation of cell suspensions and tests concerning cell 
viability have been published earlier [39]. Neurointermediate 
lobes were dissected in incubation medium (IM) containing 
112 mM NaCI, 2 mM KC1, 2 mM CAC12.2 HzO, 2 mg/ml 
glucose, 15 mM Hepes pH 7.38. The medium was preaerated 
with carbogen. The tissue was subsequently transferred to 
1.5 ml IM to which was added 3 mg/ml bovine serum albumin 
(BSA, Sigma fraction V), l mg/ml collagenase (Sigma) and 
1.25 mg/ml dispase (grade II lyophilisat, Boehringer) and in- 
cubated for 1 hr in a shaking waterbath at 22°C. After cen- 
trifugation (10 min, 200xg, 22°C) the pellet was carefully sus- 
pended in 1.5 ml Ca-free medium to which 3 mg/ml BSA and 
0.4 mg/ml EDTA were added. The suspension was cen- 
trifuged, resuspended in 1.5 ml Ca-free medium with 3 mg/ml 
BSA and 1.25 mg/ml dispase and incubated for 30 rain at 
22°C with shaking. Tissue fragments were then allowed to 
settle and the supernatant containing melanotropes in sus- 
pension (fraction I) was saved. The fragments were rinsed 
and retreated with Ca-free medium containing BSA and dis- 
pase, and centrifuged for 3 rain at 200×g over a nylon filter 
(pore size 0.15 mm). The collected cell suspension (fraction 
2) was combined with fraction 1 and centrifuged (I0 min 200x 
g). The pellet was rinsed and resuspended in medium con- 
taining 3 mg/ml BSA, 0.8 mg/ml EDTA. Finally it was cen- 
trifuged and suspended in incubation medium with 0.3 mg/ml 
BSA. All glassware was siliconized. 
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FIG. 3. A comparison of the effect of sauvagine on release of MSH and endorphin from neurointermediate lobe tissue of a 
white-background a apted Xenopus laevis. Times of sauvagine administration and concentrations u ed are indicated in the 
figure. 
Superfusion of Isolated Melanotropes 
Cells were suspended in a small volume of incubation 
medium and loaded in a 50 p.1 superfusion chamber with a 
millipore 0.45/zm filter (type HA) at the outlet to support a 
layer of biogel P2 (Biorad). After loading, the chamber was 
filled with biogel. Medium was pumped with a peristaltic 
pump at a rate of 1.5 ml/hr and 7.5 min fractions were col- 
lected in 100/~l ice-cold 0.1 N HC1. After an equilibration 
period of approximately 1 hr the effect of neuropeptides was 
investigated by giving 15 min pulses of medium containing 
CRF, sauvagine or TRH. All fractions were stored at -20°C 
before radioimmunoassay. 
Radioimmunoassays 
R1Afi~r ~-MSH. The C-terminally directed antiserum was 
characterized earlier [37]. It has equal reactivity to des- 
acetyl-c~-MSH and c~-MSH. Immunobound and unbound 
[12SI]MSH were separated either by the use of the second 
antibody technique or by precipitation with polyethyl- 
eneglycol. Sensitivity threshold of the assay is 5 pg. 
RIA for ¢3-endorphin. Endorphin was measured with an 
antiserum produced to porcine endorphin. Characteristics of
this antiserum have been published [13]. The antiserum has 
been used in earlier studies with Xenopus laevis. Dilution 
curves with Xenopus intermediate lobe extracts and incuba- 
tion media did not completely parallel those obtained with 
porcine fl-endorphin (Peninsula Lab Inc., CA). Therefore, 
within one assay all superfusion fractions were assayed at 
the same dilution. Thus the results give the relative amount 
of endorphin released but cannot be considered to be abso- 
lute values. 
RESULTS 
lmmunocytochemistry With Anti-CRF 
Very dense staining with a beaded appearance was visible 
within the median eminence of black- and white-background 
TABLE 1 
STIMULATION OF MSH RELEASE BY CRF, SAUVAGINE OR 
UROTENSIN I, DURING IN VITRO SUPERFUSION OF 
NEUROINTERMEDIATE LOBES OF BLACK- AND WHITE- 
BACKGROUND ADAPTED Xenopus laevis 
Black White 
CRF 
10 8M 112 n=l 116_+ 7n=5 
10 7 M 128 n=2 188 _+ 30 n=8 
10 -~M 152+_ 9n=7 222-+27n=7 
Sauvagine 
10 8 M 95 n=2 126 -+ 5 n=7 
10 -r M 95 n=2 162 _+ 16 n=4 
10 -6 M 126 - 12 n=8 197 _+ 24 n=9 
Urotensin I 
10 8M 130 +-- 7n=6 n.d. 
10 -~ M 135 _+ 18 n=10 124 _+ 18 n=3 
10 6 M 156 _+ 10 n=6 141 n=2 
Stimulation of MSH release was calculated in %. Basal values of 
release are calculated from the average secretion of MSH during two 
7.5-min fractions just prior to the 15-rain europeptide pulse. Per- 
centage of release in top fraction of the pulse is indicated relative to 
this basal value. Values are given -+SEM. n=number of individual 
lobes, nd=not determined. 
adapted animals (Fig. la, b, c). The intermediate lobes of all 
6 black-background a apted animals tested were devoid of 
immunostaining (Fig. 1 c). Four out of six intermediate lobes 
of white-background a apted animals showed a positive im- 
munostaining. This staining was more diffuse than that ob- 
served in the neural lobe (Fig. la, b). The pars distalis of 
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FIG. 4. Effect of TRH (10 -6 M), CRF (10 -6 M) and sauvagine (10 -6 M) on in vitro secretion of MS H from melanotrope c lls 
isolated from 2 neurointermediate lobes of black-background a apted Xenopus laevis. 
black- and white-background a apted animals was devoid of 
immunostaining. Immunoabsorption with o-CRF eliminated 
all immunostaining (Fig. ld). Immunoabsorption with 
sauvagine was also effective, although a weak reactivity re- 
mained in the region of the median eminence (not shown). 
Effect of o-CRF, Sauvagine or Urotensin I on Release of 
MSH and Endorphin During In Vitro Superfusion of 
Neurointermediate Lobe Tissue 
o-CRF and sauvagine caused a rapid stimulation of re- 
lease of MSH from neurointermediate lobe tissue of white- 
background adapted animals (Fig. 2). Lobes from black- 
background adapted animals were less responsive to these 
neuropeptides, even at 10 -6 M (Fig. 2, Table 1). The stimula- 
tion of secretion from lobes of white-background adapted 
animals was clearly dose-dependent, in a range of 10 -8 M to 
10 -6 M. The peptide urotensin I stimulated MSH secretion 
from lobes of black and white animals (Table 1). During in 
vitro superfusion, the neurointermediate lobe tissue of 
white-adapted animals howed a decreasing baseline of MSH 
release, which indicates depletion [41]. Therefore, dose- 
related responses presented in Table 1 were calculated only 
from data collected from the first 15 min pulse of neuropep- 
tide. 
Effects of either sauvagine and CRF on release of both 
endorphin and MSH were measured in media obtained from 
four superfused lobes. In all cases endorphin and MSH re- 
lease were concomitantly stimulated. Figure 3 shows an 
example of analysis of endorphin release after stimulation by 
sauvagine, together with the results of an analysis of MSH 
release from the same lobe. In those cases where during 
superfusion of white-background a apted animals the lobes 
started to become depleted, the baselines for endorphin re- 
lease decreased more rapidly than those for release of 
a-MSH. 
Effect of CRF, Sauvagine and TRH During In Vitro 
Superfusion of lsolated Melanotrope Cells 
CRF, sauvagine or TRH were administered during super- 
fusion of melanotrope cells isolated from neurointermediate 
lobe tissue of black-background a apted animals. In Fig. 4 it 
is shown that the cells remain insensitive to TRH. However, 
sauvagine and CRF clearly induced the release of MSH from 
these cells. Experiments with TRH and sauvagine were re- 
peated and gave similar results to those illustrated. Also two 
experiments with urotensin I showed that these cells are also 
responsive to this neuropeptide. 
DISCUSSION 
The immunocytochemical staining in nerve terminals in 
the median eminence and neurohypophysis indicate that a 
CRF-like peptide could be involved in the control of pituitary 
function in Xenopus laevis. From the very dense staining 
found in the median eminence we conclude that in this spe- 
cies a CRF-like peptide will likely reach the anterior pituitary 
via the portal system, possibly to regulate secretion of 
ACTH. In addition many axons run into the pars nervosa 
and thus a CRF-like peptide might ultimately reach the pars 
intermedia, either by direct innervation or by diffusion from 
the neural obe. The anti-CRF staining in the pars intermedia 
was rather diffuse and not of the beaded nature expected of 
nerve fibers. This might argue for diffuse delivery of a CRF- 
like peptide from the neural obe, although a thorough mor- 
phological study is necessary to confirm this. The fact that 
immunostaining in the pars intermedia, when observed, was 
restricted to white-adapted animals might indicate that in the 
living animal the neuropeptide is released only in this physi- 
ological state, possibly in the regulation of low basal secre- 
tion from melanotrope cells. 
Our immunocytochemical results indicate a morphologi- 
cal basis for the regulation of the pars intermedia through 
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peptides tructurally related to mammalian CRF. Nothing 
has been reported about he structure of endogenous CRF or 
sauvagine-like molecules in Xenopus laevis, and thus we are 
unable to comment on the precise nature of this immunos- 
taining. Although the ovine CRF antiserum used in the pres- 
ent study does not cross-react with synthetic sauvagine in 
radioimmunoassay procedures [19], in our histochemical 
procedure sauvagine was quite effective in absorbing the 
antiserum. 
Results of superfusion experiments with neurointer- 
mediate lobes show that o-CRF, sauvagine and urotensin I 
stimulate MSH secretion. An interesting phenomenon in this 
regard is the difference in the response to these peptides 
between lobes from black- and white-background a apted 
animals. Tissue from white-background a apted animals 
shows a higher esponse to sauvagine and CRF, a phenom- 
enon noted earlier for TRH-induced stimulation of secretion 
from intact neurointermediate lobes [42]. The observation 
that immunocytochemical staining of CRF-like material 
within the pars intermedia was restricted to white-adapted 
animals might suggest that the CRF-like peptides are only 
functional in white-adapted animals. The fact that these pep- 
tides were effective in stimulating MSH release from isolated 
melanotrope c lls shows that these neuropeptides xert heir 
effect directly on the MSH cells, rather than indirectly such 
as effecting release of other regulatory factors within the 
neurointermediate lobe tissue. 
A possible xplanation for the different response of tissue 
from black- and white-background a apted animals could be 
a ligand-induced desensitization f receptors during adapta- 
tion to black background. This supposition, however, is not 
supported by our immunocytochemical results, which indi- 
cated the presence of a CRF-like peptide in the intermediate 
lobe of white-adapted animals only. Another possibility is 
that the difference in response is related to a difference in 
intracellular mechanisms utilized by these peptides in 
stimulus-secretion coupling. For the pars intermedia of the 
rat it has been established that CRF concomitantly stimu- 
lates release of a-MSH and intracellular accumulation of 
cyclic AMP (cAMP) [15,24]. We have previously shown that 
cAMP is involved as second messenger in the regulation of 
MSH secretion from Xenopus melanotropes [40,41]. Inter- 
estingly, there is parallelism in the response of Xenopus 
melanotropes to the CRF-like peptides and to the cAMP 
analogues. As with the CRF-like peptides, 8-Br-cAMP is ef- 
fective in stimulating MSH secretion from neurointermediate 
lobe tissue of white-adapted animals, whereas lobes of 
black-background a apted animals show a poor response. 
Both CRF-like peptides and 8-Br-cAMP stimulate secretion 
of MSH from isolated melanotrope cells from black- 
background adapted animals. We have previously suggested 
that the endogenous cAMP concentration in melanotropes of 
black-background a apted animals is at a level which gives 
maximum responses and that this level drops during the 6 hr 
preparation of the cell suspension under release inhibited 
conditions [40,41]. This would render the cells sensitive to 
cAMP and to secretagogues that function through the adeny- 
late cyclase system. Our present finding that isolated 
melanotropes are almost completely insensitive to TRH 
might suggest that if this neuropeptide acts directly on the 
melanotrope c lls, it may not do so through activation of the 
adenylate cyclase system. In studies with GH3 cells TRH has 
been shown to work through mobilization of calcium [12,23]. 
An alternative xplanation is that TRH effects secretion of 
MSH in Xenopus through an indirect mechanism. 
POMC processing results in the formation of a number of 
secretory peptides and in previous biosynthetic studies we 
have examined whether or not secretagogues cause a coor- 
dinate release of newly synthesized radioactive peptides. 
These studies have shown that the inhibitory factors 
dopamine [21, 35, 39], GABA [1,43], and NPY [7,38] induce 
coordinate inhibition. The low biosynthetic activity of the 
pars intermedia of white-background adapted animals [14,45] 
prohibits extension of this analysis to the stimulatory 
neuropeptides. One of the important POMC-derived pep- 
tides is endorphin. Secretion of endorphin from Xenopus 
neurointermediate lobes can be analyzed with a radioim- 
munoassay to/3-endorphin [38,43]. Using this assay GABA- 
and NPY-induced inhibition of immunoreactive endorphin 
was established. The present results show that there is a 
coordinate stimulation of endorphin and MSH secretion by 
CRF and sauvagine. 
Our results suggest that the pars intermedia of Xenopus 
laevis is under dual regulation which involves not only the 
well established inhibitory mechanisms but also stimulatory 
neuropeptides. Many of the inhibitory factors have been 
shown to work directly on the melantrope cells, an observa- 
tion which is now extended to the stimulatory action of the 
CRF-related peptides. Therefore, the neuroendocrine r gu- 
lation of the pars intermedia seems to be very complex, with 
the melanotropic cell itself acting as a centre of integration 
for the hypothalamic input. Such complexity is surprising in 
view of the fact that the functioning of the pas intermedia of 
amphibians i at first glance rather simple: production and 
secretion of MSH in animals on black background, storage of 
the peptide in animals on a white background. In evaluating 
the possible significance of this complex system, one should 
also consider the possibility that regulation of the dermal 
melanophores could involve not only input concerning the 
color of background but also other parameters such as tem- 
perature, stress and temporal factors. Unfortunately, little is 
known concerning the physiological functioning of dermal 
melanophores, other than during background adaptations. 
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